Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 07, 2015 2:26 AM ET

Healthcare Equipment and Supplies

Company Overview of Zimmer, Inc.

Company Overview

Zimmer, Inc. designs, manufactures, and markets orthopedic reconstructive products, spinal and trauma devices, dental implants, and related surgical products for customers around the world. It offers a range of orthopaedic products, such as knee replacement and hip replacement products, shoulder surgery products, dental implants, trauma products and instrumentation, spine surgery products, foot and ankle systems, hand and wrist surgery products, and more. The company also provides elbow products; biologics and sports medicine solutions for early intervention treatment; surgical and operating room solutions; procedural spine surgery solutions for thoracolumbar, cervical fixation, and biologic...

1800 West Center Street

P.O. Box 708

Warsaw, IN 46581-0708

United States

Founded in 1927

Phone:

800-348-2759

Fax:

574-371-8755

Key Executives for Zimmer, Inc.

Chief Executive Officer, President, Director, Chief Executive Officer of Zimmer Holdings Inc and President of Zimmer Holdings Inc
Age: 50
Chief Financial Officer and Executive Vice President of Finance
Age: 54
President of Americas
Age: 54
Compensation as of Fiscal Year 2014.

Zimmer, Inc. Key Developments

FDA Announces Class II Recall of Zimmer Inc.'s Persona Trabecular Metal Tibial Plate

The U.S. Food and Drug Administration (FDA) issued a notice on March 12, 2015, for a Class II recall for all lots and sizes of the Zimmer Persona Trabecular Metal Tibial Plate knee implant. Zimmer Inc. is initiating a voluntary recall of Persona Trabecular Metal Tibial following an increase in complaints of radiolucent lines and loosening. All sizes and lots of the affected devices are being removed from distribution. The FDA will issue a Class II Recall when a product can "cause temporary or medically reversible adverse health consequences." However, problems associated with this Zimmer knee implant can cause serious complications and patients implanted with the Persona® Trabecular Metal™ Tibial Plate can face the risk of loosening of their tibial component. Indications of loosening include radiolucent lines on imaging tests, which are large gaps between the device and bone. Loosening can cause pain and significant mobility problems, and generally requires the patient to undergo additional surgery to remove and replace the loose tibial component. Zimmer Inc.'s voluntary recall is the latest headline in a number of highly publicized medical device recalls.

MiMedx Group, Inc. Signs Distribution Agreement with Zimmer, Inc

MiMedx Group, Inc. announced that it has entered into a distribution agreement with Zimmer, Inc. Through the agreement, MiMedx will provide its dehydrated human amnion/chorion membrane ("dHACM") allograft products to Zimmer to be marketed non- exclusively on a private label basis. The MiMedx dHACM allografts, processed utilizing the company's proprietary PURION(R) process, will be provided to Zimmer for marketing under Zimmer's private-label. Through-out the United States, Zimmer will market and sell the private-labeled allografts to Zimmer customers and end-users. The distribution agreement encompasses a range of musculoskeletal applications to include reconstructive, sports medicine, trauma, extremities and spinal applications.

Zimmer and Biomet Receives a Request for Additional Information from the U.S. Federal Trade Commission

Zimmer and Biomet each received a request for additional information from the U.S. Federal Trade Commission (FTC) in connection with Zimmer's proposed $13.4 billion acquisition of Biomet. This second request will extend the waiting period until 30 days after Zimmer and Biomet have substantially complied with the request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC.

Similar Private Companies By Industry

Company Name Region
Muroplex Therapeutics, Inc. United States
MAQUET Cardiovascular LLC United States
Little Rapids Corporation United States
eCardio Diagnostics, LLC United States
PlaCor, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Zimmer, Inc., please visit www.zimmer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.